Improving the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting: The IMPROVE HF performance improvement registry
To access this article, please choose from the options below
This registry is supported by Medtronic, Inc, Minneapolis, MN.
The IMPROVE HF registry and this study are sponsored by Medtronic, Inc. The IMPROVE HF registry was established by Medtronic, Inc, under the guidance of a steering committee of academic advisors, each of whom is an author on this manuscript. The financial disclosures of the IMPROVE HF steering committee members are given below. These academic advisors were intimately involved in the initial preparation and design of this registry. Medtronic, Inc, provided financial and material support for the IMPROVE HF registry. A contract research organization, Outcome Sciences, Inc (Cambridge, MA), independently performs the practice site chart abstractions for IMPROVE HF and is responsible for performing data checks, storing site-specific and aggregate data, as well as providing benchmarked quality of care reports to practice sites. The contract research organization receives funding from Medtronic, Inc. Identified, individual practice site data are not shared with either the steering committee or the sponsor. The authors had complete control and authority over the study design, the manuscript preparation, and the decision to submit this manuscript to the American Heart Journal for publication. The manuscript was submitted to Medtronic, Inc, prior to submission for publication.
PII: S0002-8703(07)00254-2
doi:10.1016/j.ahj.2007.03.030
© 2007 Published by Elsevier Inc.
